31 results
424B4
RNAZ
TransCode Therapeutics Inc
19 Jan 24
Prospectus supplement with pricing info
9:57pm
regulatory authority approves our therapeutic candidates, the manufacturing processes, labeling, packaging, distribution, adverse event reporting, storage … , among other things, the research, development, testing, manufacture, quality control, import, export, safety, effectiveness, labeling, packaging
8-K
EX-10.1
gxb8r
4 Dec 23
TransCode Therapeutics Announces $1.2 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
5:07pm
8-K
EX-10.1
6qh442oqvih8m0
8 Jun 23
TransCode Therapeutics Announces Pricing of $7 Million Public Offering
5:25pm
DRS
pmcty2eoza
29 Jul 22
Draft registration statement
12:00am
10-K
fwnvvbreeh 4yta
31 Mar 22
Annual report
11:19am